Search results for: 'china cell and gene therapy industry development waste part'

19 May 2017  |  Asia Pacific  |  Market Research

Strategic Analysis of Autonomous Cars in China, 2010–2025

Autonomous Cars Likely to be Commercialized among OEMs in China by 2030

Infographics

×

China is the largest passenger vehicle marketplace in term of sales and production volume in the world. Strong capitalization and the fast-growing automotive industry in China are likely to create high development opportunities in the global autonomous car market. The Chinese automotive industry is moving into autonomous car development. It is at t...

16 Aug 2021  |  Global  |  Technology Research

Recent Trends and Innovations Facilitating COVID-19 Waste Management

Technological advancements in biohazardous waste handling and treatment methods to facilitate the development of effective COVID-19 waste management ecosystem

Infographics

×

Waste management technologies are amongst the most important tools we can deploy to reduce our impact on nature. Further, efficient and eco-friendly waste management solutions also enable a healthy environment by reducing the probability of contagion transmissions. During the pre-COVID period, efficient and effective waste collection and treatment/...

This edition of the Industrial Bioprocessing TOE features information on innovations in carbon capture technologies, catalytic hydrothermal gasification, advanced fermentation technology, waste-to-energy processes, precision-fermentation, and animal-free milk proteins, among others.The Industrial Bioprocessing TOE provides intelligence on technolog...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

China's economy is poised for steady growth, projecting a 4.8% increase in GDP for 2024, following a 5.2% rise in 2023. This growth is supported by robust public investment, a resurgence in private consumption, and increased net exports. However, challenges such as an aging labor force, escalating debt levels, and geopolitical tensions around Taiwa...

This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...